101 results
8-K
EX-99.1
ABBV
Abbvie Inc
20 Feb 24
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
9:00am
a tremendous impact on AbbVie. From establishing our financial planning organization, to the development of our diversified business strategy … an important role in key business development opportunities that have been critical to delivering on our long-term growth strategy, including the acquisitions
8-K
EX-99.1
62418h7u
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
8-K
f6dc4iq2
29 Jun 23
Departure of Directors or Certain Officers
5:00pm
SD
EX-1.01
opx 3kyfm28m3aqu9
31 May 23
Conflict minerals disclosure
4:59pm
PX14A6G
yzuvm67ya4 cggo
4 May 23
Letter to shareholders
8:08am
PX14A6G
7fn82 yamoq
11 Apr 23
Letter to shareholders
12:34pm
8-K
EX-99.1
clj z6omwi
17 Oct 22
Departure of Directors or Certain Officers
9:05am
SD
EX-1.01
500ydae m9m8h
31 May 22
Conflict minerals disclosure
5:01pm
PX14A6G
bb86jmv90p
11 Apr 22
Letter to shareholders
4:35pm
PX14A6G
amtsv
4 Apr 22
Letter to shareholders
8:36am
PX14A6G
f6o78j9bx2ss5upmi
30 Mar 22
Letter to shareholders
4:39pm